PepGen Inc. (PEPG)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch PEPG
See up to 3 months of PEPG. The 7-day demo opens the 1M and 3M ranges and puts PEPG on your watchlist.
Start 7-day demoLatest PEPG insider trades
About PepGen Inc. (PEPG)
PepGen Inc. files with the SEC under CIK 0001835597 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
PEPG Form 4 activity by transaction type, last 90 days
No Form 4 activity for PEPG in the last 90 days.
PEPG insider transactions (Form 4)
5423 Form 4 filings on record, the earliest from Jun 4, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Lisa Wyman - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Joshua Resnick - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
 Howard Mayer - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Mitchell H. Finer - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Habib J. Dable - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Heidi Henson - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Laurie Keating - Director | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Kasra Kasraian - Officer | Open-market sale | Common Stock | 1,233 | $1.41 footnote F2 | $2K | |
| ||||||
| Paul Streck - Officer | Open-market sale | Common Stock | 1,832 | $6.23 | $11K | |
| Paul Streck - Officer | Open-market sale | Common Stock | 47 | $6.29 | $296 | |
| Noel Donnelly - Officer | Open-market sale | Common Stock | 2,032 | $6.23 | $13K | |
| Noel Donnelly - Officer | Open-market sale | Common Stock | 52 | $6.33 | $329 | |
| James G. McArthur - Officer | Open-market sale | Common Stock | 5,144 | $6.23 | $32K | |
| James G. McArthur - Officer | Open-market sale | Common Stock | 131 | $6.33 | $829 | |
| Joseph Vittiglio - Officer | Grant or award | Common Stock | 30,717 footnote F1 | $0.00 | - | |
| Joseph Vittiglio - Officer | Grant or award | Stock Option (Right to Buy) | 120,000 | $0.00 | - | |
| ||||||
| Kasra Kasraian - Officer | Grant or award | Common Stock | 34,557 footnote F1 | $0.00 | - | |
| Kasra Kasraian - Officer | Grant or award | Stock Option (Right to Buy) | 135,000 | $0.00 | - | |
| ||||||
| Paul Streck - Officer | Grant or award | Common Stock | 50,300 footnote F1 | $0.00 | - | |
| Paul Streck - Officer | Grant or award | Stock Option (Right to Buy) | 196,500 | $0.00 | - | |
| ||||||
| Noel Donnelly - Officer | Grant or award | Common Stock | 76,793 footnote F1 | $0.00 | - | |
| Noel Donnelly - Officer | Grant or award | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| ||||||
| James G. McArthur - Officer | Grant or award | Common Stock | 187,688 footnote F1 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 731,250 | $0.00 | - | |
| ||||||
| Paul Streck - Officer | Derivative | Stock Option (Right to Buy) | 202,816 | $0.00 | - | |
| Paul Streck - Officer | Grant or award | Stock Option (Right to Buy) | 202,816 | $0.00 | - | |
| Paul Streck - Officer | Derivative | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Paul Streck - Officer | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 352,705 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 352,705 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 40,815 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 40,815 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 40,815 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 40,815 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 40,815 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 40,815 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 466,095 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 466,095 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 275,000 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 275,000 | $0.00 | - | |
| James G. McArthur - Officer | Derivative | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| James G. McArthur - Officer | Grant or award | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Noel Donnelly - Officer | Derivative | Stock Option (Right to Buy) | 203,339 | $0.00 | - | |
| Noel Donnelly - Officer | Grant or award | Stock Option (Right to Buy) | 203,339 | $0.00 | - | |
| Noel Donnelly - Officer | Derivative | Stock Option (Right to Buy) | 169,037 | $0.00 | - | |
| Noel Donnelly - Officer | Grant or award | Stock Option (Right to Buy) | 169,037 | $0.00 | - | |
| Noel Donnelly - Officer | Derivative | Stock Option (Right to Buy) | 144,000 | $0.00 | - | |
| Noel Donnelly - Officer | Grant or award | Stock Option (Right to Buy) | 144,000 | $0.00 | - | |
| Noel Donnelly - Officer | Derivative | Stock Option (Right to Buy) | 144,000 | $0.00 | - | |
| Noel Donnelly - Officer | Grant or award | Stock Option (Right to Buy) | 144,000 | $0.00 | - | |
| Oxford Science Enterprises plc | Open-market purchase | Common Stock | 200,000 | $3.20 | $640K | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Common Stock | 9,375,000 | $3.20 | $30.00M | |
| Heidi Henson - Director | Grant or award | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
Item 2.02, 7.01, 8.01, 9.01
Item 5.07
Item 7.01, 9.01
Item 2.02, 9.01
PEPG insider trading FAQ
What is the latest insider trade for PEPG?
PepGen Inc. (PEPG) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-22. The full record for PEPG runs to 23 Form 4 filings, the earliest from 2025-06-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PEPG stock?
No insider purchases of PEPG were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling PEPG stock?
No insider sales of PEPG were filed in the last 90 days. 7 sales are on record for this company.
Where can I see PEPG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PEPG Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Lisa Wyman view on EDGAR
- - Joshua Resnick view on EDGAR
- - Howard Mayer view on EDGAR
- - Mitchell H. Finer view on EDGAR
- - Habib J. Dable view on EDGAR
- - Heidi Henson view on EDGAR
- - Laurie Keating view on EDGAR
- - Kasra Kasraian view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PEPG's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PEPG with a 7-day demo
- PEPG on your watchlist
- Every PEPG Form 4 filing on record
- Up to 3 months of PEPG price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
